Kennedy Investment Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$705K Sell
1,946
-118
-6% -$40.4K 0.24% 85
2026
Q1
$726K Buy
2,064
+74
+4% +$26.4K 0.28% 80
2025
Q4
$651K Sell
1,990
-10
-0.5% -$3.17K 0.25% 86
2025
Q3
$564K Sell
2,000
-40
-2% -$11.6K 0.22% 87
2025
Q2
$570K Sell
2,040
-28
-1% -$7.93K 0.24% 87
2025
Q1
$644K Sell
2,068
-20
-1% -$5.91K 0.3% 77
2024
Q4
$544K Buy
2,088
+18
+0.9% +$5.34K 0.25% 81
2024
Q3
$667K Sell
2,070
-109
-5% -$35.7K 0.31% 76
2024
Q2
$681K Sell
2,179
-5
-0.2% -$1.47K 0.34% 68
2024
Q1
$621K Buy
2,184
+22
+1% +$6.44K 0.33% 74
2023
Q4
$623K Buy
2,162
+79
+4% +$21.5K 0.35% 74
2023
Q3
$560K Buy
2,083
+16
+0.8% +$3.99K 0.34% 75
2023
Q2
$459K Buy
2,067
+9
+0.4% +$2.09K 0.27% 79
2023
Q1
$498K Sell
2,058
-15
-0.7% -$3.68K 0.3% 79
2022
Q4
$544K Buy
+2,073
New +$556K 0.35% 73

Other funds holding AMGN

Kennedy Investment Group's AMGN Position: Q2 2026 in Review

Kennedy Investment Group reduced its Amgen (AMGN) stake by 5.7% in Q2 2026, selling an estimated $40.4K and leaving 1,946 shares worth $705K. The position accounts for 0.24% of the portfolio, ranked #85.

Kennedy Investment Group first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $726K in Q1 2026. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Kennedy Investment Group held 1,946 shares of Amgen worth $705K as of Q2 2026.
  • Kennedy Investment Group sold 118 Amgen shares in Q2 2026, an estimated $40.4K.
  • Amgen made up 0.24% of Kennedy Investment Group's portfolio in Q2 2026, its #85 holding.
  • Kennedy Investment Group first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • Kennedy Investment Group's Amgen position peaked at $726K in Q1 2026.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Kennedy Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.